福安药业：子公司盐酸曲唑酮片获药品注册证书

Core Viewpoint - Fuan Pharmaceutical has received a drug registration certificate for its product, Clomipramine Hydrochloride Tablets, from the National Medical Products Administration, indicating a significant advancement in its product portfolio [1] Group 1: Company Developments - Fuan Pharmaceutical's wholly-owned subsidiary, Ningbo Tianheng Pharmaceutical Co., Ltd., has been granted a registration certificate for Clomipramine Hydrochloride Tablets [1] - The tablets are available in two specifications: 50mg and 100mg [1] Group 2: Product Information - Clomipramine Hydrochloride Tablets are indicated for the treatment of depression, effective for patients with or without anxiety [1]